Stay updated with breaking news from Tim Walbert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Tepezza (teprotumumab-trbw) labeling has been updated to specify for the treatment of thyroid eye disease regardless of TED activity or duration.
The new drug looked so promising — except for that one warning sign.
Horizon Therapeutics, which Amgen is acquiring for about $28 billion, grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.